Beta-Blockers in Pediatric Hypertrophic Cardiomyopathies
Congestive cardiac failure accounts for 36% of childhood deaths in hypertrophic cardiomyopathy, and in infants with heart failure symptoms before two years of age, the mortality is extremely high unless treatment with beta-receptor antagonists is instituted. The mechanism of heart failure is not sys...
| Main Author: | |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Bentham Science Publishers
2014
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4443781/ |